Dyne Therapeutics
127 hedge funds and large institutions have $629M invested in Dyne Therapeutics in 2023 Q1 according to their latest regulatory filings, with 20 funds opening new positions, 54 increasing their positions, 30 reducing their positions, and 6 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
10% more capital invested
Capital invested by funds: $571M → $629M (+$57.8M)
1.58% more ownership
Funds ownership: 95.38% → 96.96% (+1.6%)
0% more funds holding in top 10
Funds holding in top 10: 3 → 3 (0)
Holders
127
Holding in Top 10
3
Calls
$176K
Puts
$5K
Top Buyers
| 1 | +$19M | |
| 2 | +$7.98M | |
| 3 | +$7.59M | |
| 4 |
B
Braidwell
Stamford,
Connecticut
|
+$7.2M |
| 5 |
WA
Wasatch Advisors
Salt Lake City,
Utah
|
+$4.7M |
Top Sellers
| 1 | -$5.37M | |
| 2 | -$5.31M | |
| 3 | -$5.18M | |
| 4 |
DTC
Deep Track Capital
Greenwich,
Connecticut
|
-$4.03M |
| 5 |
IBT
International Biotechnology Trust
London,
United Kingdom
|
-$2.38M |